Contact Us  I  Home 

Home

About The Epsilon Group

 

The Epsilon Group (TEG) combines contract research organization capabilities with strategic advisory services to formulate evidence-based strategy, identify market opportunities through research, and translate new knowledge into sales and market share.

 

TEG partners with clients to identify strategic research questions and design studies that will definitively answer clinical questions while enhancing the practice of medicine. Experience with real-world patient care combined with marketing insight allows TEG to design and implement studies that advance scientific knowledge and support a client’s long-term strategy.

 

With appropriate use of the latest technology, this data is acquired and analyzed quickly then professionally disseminated through our efficient technical and scientific communication strategies. The new information acquired is the basis for evidence-based clinician and consumer education to improve medical outcomes and increase our client’s market share.

 

Epsilon possesses the unique combination of clinical experience, scientific expertise, and strategic skills needed to identify your knowledge and data needs, profile your marketplace, and map a campaign to increase sales. We provide you with an evidence-based framework to move forward rapidly and decisively.

 

Our Philosophy

 

It is not enough to compile information and build knowledge – only when it is widely disseminated does knowledge build momentum for your product. And that is where TEG excels. We help you reach your target audience, from your sales force to clinicians to patients. And we craft just the right tools to reach them most effectively, from white papers and journal articles to lecture series and customized reports and presentations. Throughout, we emphasize evidence-based support as the driver of progress in healthcare.

Latest News

 

First FDA-Accepted Type 1 Diabetes Metabolic Simulator Now Available

The T1DMS provides a safe, interactive modeling and learning environment for the research/training/ education of study investigators, healthcare providers and patients and families managing their disease towards improved glucose control. 

Press Release
T1DM Product Page
T1DM Services Page

MAS-EPSILON Licenses SAAM II Software from the University of Washington Center for Commercialization. MAS-EPSILON  plans to support current +5000 user group with ongoing educational webinars, NIH courses and upgrade software to using current robust statistical analysis and graphics tools. Press Release
SAAM II Website
© 2011 The Epsilon Group., Charlottesville, VA USA. All rights reserved.